122 related articles for article (PubMed ID: 35064597)
1. Clinical utility of a serum glycome analysis in patients with colorectal cancer.
Takei D; Harada K; Nouso K; Miyahara K; Dohi C; Matsushita H; Kinugasa H; Hiraoka S; Nishimura SI; Okada H
J Gastroenterol Hepatol; 2022 Apr; 37(4):727-733. PubMed ID: 35064597
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
Nouso K; Amano M; Ito YM; Miyahara K; Morimoto Y; Kato H; Tsutsumi K; Tomoda T; Yamamoto N; Nakamura S; Kobayashi S; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Nakahara T; Nishimura S; Yamamoto K
J Gastroenterol; 2013 Oct; 48(10):1171-9. PubMed ID: 23307043
[TBL] [Abstract][Full Text] [Related]
3. Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
Miyahara K; Nouso K; Saito S; Hiraoka S; Harada K; Takahashi S; Morimoto Y; Kobayashi S; Ikeda F; Miyake Y; Shiraha H; Takaki A; Okada H; Amano M; Hirose K; Nishimura S; Yamamoto K
PLoS One; 2013; 8(10):e74861. PubMed ID: 24116015
[TBL] [Abstract][Full Text] [Related]
4. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.
Zhang D; Xie Q; Wang Q; Wang Y; Miao J; Li L; Zhang T; Cao X; Li Y
Glycobiology; 2019 May; 29(5):372-384. PubMed ID: 30698702
[TBL] [Abstract][Full Text] [Related]
6. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
Yamasaki Y; Nouso K; Miyahara K; Wada N; Dohi C; Morimoto Y; Kinugasa H; Takeuchi Y; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Amano M; Nishimura S; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):528-34. PubMed ID: 25168691
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.
Gu Y; Duan B; Sha J; Zhang R; Fan J; Xu X; Zhao H; Niu X; Geng Z; Gu J; Huang B; Ren S
Int J Cancer; 2023 Feb; 152(3):536-547. PubMed ID: 36121650
[TBL] [Abstract][Full Text] [Related]
8. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.
Akimoto Y; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Tomoda T; Yamamoto N; Tsutsumi K; Kuwaki K; Onishi H; Ikeda F; Nakamura S; Shiraha H; Takaki A; Okada H; Amano M; Nishimura S; Yamamoto K
Pancreatology; 2015; 15(4):432-8. PubMed ID: 26052067
[TBL] [Abstract][Full Text] [Related]
9. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
10. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling.
Zhao YP; Ruan CP; Wang H; Hu ZQ; Fang M; Gu X; Ji J; Zhao JY; Gao CF
Cancer; 2012 Feb; 118(3):639-50. PubMed ID: 21853445
[TBL] [Abstract][Full Text] [Related]
11. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Narita T; Hatakeyama S; Yoneyama T; Narita S; Yamashita S; Mitsuzuka K; Sakurai T; Kawamura S; Tochigi T; Takahashi I; Nakaji S; Tobisawa Y; Yamamoto H; Koie T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
Cancer Med; 2017 Apr; 6(4):739-748. PubMed ID: 28317343
[TBL] [Abstract][Full Text] [Related]
13. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
14. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
15. Comparison of N-glycans expressed in tumor tissues with those expressed in adjacent non-tumor tissues of colorectal cancer patients
.
Ji E
Int J Clin Pharmacol Ther; 2019 May; 57(5):249-258. PubMed ID: 30738496
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
17. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
18. Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis.
Li H; Wang X; Huang X; He Y; Zhang Y; Hao C; Zeng P; Zhang M; Gao Y; Yang D; Shan M; Dou H; Li X; Chang X; Tian Z; Zhang L
Front Oncol; 2022; 12():852044. PubMed ID: 35574422
[TBL] [Abstract][Full Text] [Related]
19. Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.
Pan Y; Zhang L; Zhang R; Han J; Qin W; Gu Y; Sha J; Xu X; Feng Y; Ren Z; Dai J; Huang B; Ren S; Gu J
Am J Cancer Res; 2021; 11(6):3002-3020. PubMed ID: 34249441
[TBL] [Abstract][Full Text] [Related]
20. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
